DE69523864T2 - PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE - Google Patents

PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE

Info

Publication number
DE69523864T2
DE69523864T2 DE69523864T DE69523864T DE69523864T2 DE 69523864 T2 DE69523864 T2 DE 69523864T2 DE 69523864 T DE69523864 T DE 69523864T DE 69523864 T DE69523864 T DE 69523864T DE 69523864 T2 DE69523864 T2 DE 69523864T2
Authority
DE
Germany
Prior art keywords
halogen
alkyl
phenyl
substituted
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69523864T
Other languages
English (en)
Other versions
DE69523864D1 (de
Inventor
Yasuo Shoji
Makoto Inoue
Takashi Okamura
Kinji Hashimoto
Masayuki Ohara
Tsuneo Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69523864D1 publication Critical patent/DE69523864D1/de
Publication of DE69523864T2 publication Critical patent/DE69523864T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69523864T 1994-06-21 1995-06-05 PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE Expired - Fee Related DE69523864T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13863594 1994-06-21
JP5399795 1995-03-14
PCT/JP1995/001104 WO1995035298A1 (fr) 1994-06-21 1995-06-05 DERIVE DE PYRAZOLO[1,5-a]PYRIMIDINE

Publications (2)

Publication Number Publication Date
DE69523864D1 DE69523864D1 (de) 2001-12-20
DE69523864T2 true DE69523864T2 (de) 2002-06-13

Family

ID=26394734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523864T Expired - Fee Related DE69523864T2 (de) 1994-06-21 1995-06-05 PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE

Country Status (13)

Country Link
US (1) US5707997A (de)
EP (1) EP0714898B1 (de)
KR (1) KR100315837B1 (de)
CN (1) CN1046730C (de)
AT (1) ATE208776T1 (de)
AU (1) AU680370B2 (de)
CA (1) CA2169719C (de)
DE (1) DE69523864T2 (de)
DK (1) DK0714898T3 (de)
ES (1) ES2164153T3 (de)
PT (1) PT714898E (de)
TW (1) TW307767B (de)
WO (1) WO1995035298A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0795555A4 (de) * 1995-09-28 1998-01-07 Otsuka Pharma Co Ltd Analgetika
US6664261B2 (en) 1996-02-07 2003-12-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines as CRF receptor antagonists
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
ATE375344T1 (de) * 1996-07-24 2007-10-15 Bristol Myers Squibb Pharma Co Azolotriazine und pyrimidine
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
ID23177A (id) * 1997-03-14 2000-03-23 Otsuka Pharma Co Ltd Turunan pirimidin baru
AU2321000A (en) * 1999-01-29 2000-08-18 Sumitomo Chemical Company, Limited Fat accumulation inhibitory agents
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
WO2000059908A2 (en) 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US20020061897A1 (en) 2000-03-30 2002-05-23 Elliott Richard L. Neuropeptide Y antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
CA2465326C (en) * 2001-11-01 2011-03-29 Icagen, Inc. Pyrazolopyrimidines for decreasing ion flow through a voltage-dependent sodium channel
US20040028716A1 (en) * 2002-06-14 2004-02-12 Marks Andrew R. Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation
ATE376548T1 (de) 2002-09-04 2007-11-15 Schering Corp Pyrazolopyrimidine als hemmstoffe cyclin- abhängiger kinasen
US7205308B2 (en) 2002-09-04 2007-04-17 Schering Corporation Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
US7119200B2 (en) 2002-09-04 2006-10-10 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US8673924B2 (en) 2002-09-04 2014-03-18 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
MY138201A (en) 2002-09-04 2009-05-29 Schering Corp Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
JP2006500391A (ja) * 2002-09-04 2006-01-05 シェーリング コーポレイション サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン
US7196078B2 (en) 2002-09-04 2007-03-27 Schering Corpoartion Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7161003B1 (en) * 2002-09-04 2007-01-09 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
DE60313872T2 (de) 2002-09-04 2008-01-17 Schering Corp. Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
ES2285164T3 (es) 2002-09-04 2007-11-16 Schering Corporation Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina.
US8580782B2 (en) 2002-09-04 2013-11-12 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
US6949895B2 (en) * 2003-09-03 2005-09-27 Axcelis Technologies, Inc. Unipolar electrostatic quadrupole lens and switching methods for charged beam transport
PE20051089A1 (es) * 2004-01-22 2006-01-25 Novartis Ag Derivados de pirazolo [1,5-a] pirimidin-7-il-amina como inhibidores de quinasa de proteina
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
GB0519957D0 (en) 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
TW200639163A (en) 2005-02-04 2006-11-16 Genentech Inc RAF inhibitor compounds and methods
CN101128466A (zh) * 2005-03-01 2008-02-20 巴斯福股份公司 5,6-二烷基-7-氨基唑并嘧啶、其制备方法及其在防治病原性真菌中的用途以及包含这些化合物的组合物
TW200643022A (en) * 2005-03-02 2006-12-16 Basf Ag 2-substituted 7-aminoazolopyrimidines, processes for their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
EP1931641B1 (de) * 2005-09-09 2010-08-25 Schering Corporation Neue 4-cyano-, 4-amino-, und 4-aminomethylderivative von pyrazolo[1,5-a]pyridinen, pyrazolo[1,5-c]pyrimidinen und 2h-indazolverbindungen und 5-cyano-, 5-amino- und 5-aminomethylderivative von imidazo[1,2-a]pyridinen, und imidazo[1,5-a]pyrazinverbindungen als inhibitoren der cyclinabhänggen kinase
RU2008117298A (ru) 2005-10-06 2009-11-20 Шеринг Корпорейшн (US) Пиразолопиримидины как ингибиторы протеинкиназ
EA018036B1 (ru) * 2006-11-27 2013-05-30 Х. Лундбекк А/С Гетероариламидные производные
NZ580394A (en) * 2007-04-10 2011-10-28 Lundbeck & Co As H Heteroaryl amide analogues as p2x7 antagonists
AR076221A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
CA2852939A1 (en) * 2011-10-20 2013-04-25 Glaxosmithkline Llc Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
US9957271B2 (en) 2011-10-20 2018-05-01 Glaxosmithkline Llc Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
AR085073A1 (es) * 2012-01-11 2013-09-11 Richmond Sa Com Ind Y Financiera Lab Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden
EP3087069B1 (de) 2013-12-23 2019-01-30 Norgine B.V. Als ccr9-modulatoren verwendbare verbindungen
US20170002011A1 (en) * 2013-12-23 2017-01-05 Norgine B.V. Benzene sulfonamides as ccr9 inhibitors
WO2015143652A1 (en) * 2014-03-26 2015-10-01 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
MX2021004769A (es) 2018-10-30 2021-08-24 Kronos Bio Inc Compuestos, composiciones, y metodos para modular la actividad cdk9.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792533A (fr) * 1971-12-09 1973-06-08 Int Chem & Nuclear Corp Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation
US3925385A (en) * 1972-04-20 1975-12-09 Icn Pharmaceuticals 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines
JPS6157587A (ja) * 1984-08-29 1986-03-24 Shionogi & Co Ltd 縮合複素環誘導体および抗潰瘍剤
US4950585A (en) * 1987-08-18 1990-08-21 Konica Corporation Coupler for photographic use
JP2585462B2 (ja) * 1989-10-25 1997-02-26 株式会社大塚製薬工場 ピラゾロ[1,5―a]ピリミジン誘導体
DE69130683T2 (de) * 1991-04-22 1999-05-06 Otsuka Pharma Co Ltd PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL
CA2117096C (en) * 1991-09-06 1997-11-04 Masafumi Arita 4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals

Also Published As

Publication number Publication date
EP0714898B1 (de) 2001-11-14
DK0714898T3 (da) 2002-03-18
CN1131948A (zh) 1996-09-25
WO1995035298A1 (fr) 1995-12-28
CA2169719C (en) 2002-04-16
ATE208776T1 (de) 2001-11-15
TW307767B (de) 1997-06-11
ES2164153T3 (es) 2002-02-16
KR100315837B1 (ko) 2002-02-28
CA2169719A1 (en) 1995-12-28
EP0714898A4 (de) 1997-04-02
DE69523864D1 (de) 2001-12-20
EP0714898A1 (de) 1996-06-05
KR960703919A (ko) 1996-08-31
PT714898E (pt) 2002-04-29
AU2576595A (en) 1996-01-15
US5707997A (en) 1998-01-13
AU680370B2 (en) 1997-07-24
CN1046730C (zh) 1999-11-24

Similar Documents

Publication Publication Date Title
DE69523864T2 (de) PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE
FI906204A0 (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
EP0945452A4 (de) Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen
EP0955293A4 (de) Neue harnstoffderivate
CA2239245A1 (en) N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same
BR9608040A (pt) Composto pentacíclico
ES2063300T3 (es) Derivado de acido aminobencensulfonico.
MY141488A (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
DE60132484D1 (de) Chinazolinderivate und -arzneimittel
EP0335979A4 (en) Thienopyrimidine derivatives
AU5387990A (en) Thiazole derivatives
PT852226E (pt) Derivados de pirimidina
AU623500B2 (en) Carboxylimino benzothiazole derivatives
ES2159729T3 (es) Derivados de pirazolo(1,5-a)pirimidina.
ES2033523T3 (es) Un derivado de tioformamida.
WO1996022286A3 (en) Arthropodicidal oxazines and thiazines
EP0418655A3 (en) Conjugated gamma-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee